Clinical Trials Directory

Trials / Completed

CompletedNCT06482619

Effects of Creatine and Rehabilitation Programin Athletes With Patellar Tendinopathy

Effects of Creatine Supplementation in Combination With a Rehabilitation Program Physical in Athletes With Patellar Tendinopathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Universidad Pontificia Comillas · Academic / Other
Sex
Male
Age
18 Years – 49 Years
Healthy volunteers
Not accepted

Summary

The aim of this study are to analyze the effect of creatine ingestion in pain, histological properties of the tendon, body composition, strength and vertical jump performance in athletes with patellar tendinopathy that follow a physical rehabilitation program that include eccentric exercise combined with stretching and extracorporeal shock wave therapy.

Detailed description

Nutrition could play an important role in the rehabilitation from sport injuries. This afirmation is based on studies that analyze the impact of different dietary supplements along immobilization periods, stablishing that creatine, leucine and omega-3 fatty acid supplementation could ameliorate muscle loss, while creatine could potentiate the hypertrophy along the rehabilitation process. For this reason, the aim of this study are to analyze the effect of creatine ingestion in pain, histological properties of the tendon, body composition, strength and vertical jump performance in athletes with patellar tendinopathy that follow a physical rehabilitation program that include eccentric exercise combined with stretching and extracorporeal shock wave therapy.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCreatine supplementationThe supplements were provided in capsules of 1 g of red color not transparent Guinama S.L.U, 0044634, La Pobla de Valbona, Spain) which were prepared with a Capsunorm 2000 semi-automatic manual capsule filling machine (Miranda del Ebro, Spain). Capsules contained creatine monohidrate (Creapure, Crown Sport Nutrition, Arnedo, Spain)
DIETARY_SUPPLEMENTPlaceboThe supplements were provided in capsules of 1 g of red color not transparent Guinama S.L.U, 0044634, La Pobla de Valbona, Spain) which were prepared with a Capsunorm 2000 semi-automatic manual capsule filling machine (Miranda del Ebro, Spain). Capsules contained placebo (i.e., sucrose)

Timeline

Start date
2021-01-01
Primary completion
2023-08-30
Completion
2023-11-01
First posted
2024-07-01
Last updated
2024-07-01

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06482619. Inclusion in this directory is not an endorsement.